Preclinical Investigation of the Safety of Eplir

Author： Saratikov A. Livshits N. Burchenkova F. Kadychagova N. Novozheeva T. Akhmedzhanov R. Perevozchikova T. Bashirova L.

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.39, Iss.2, 2005-02, pp. : 64-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologics Safety Preclinical, Clinical and Regulatory

By Hennig Renald

Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. : 609-611

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Preclinical Safety Evaluation of Recombinant Human Interleukin-10

By Rosenblum I.Y. Johnson R.C. Schmahai T.J.

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 1, 2002-02 ,pp. : 56-71

Elsevier

Access to resources Recommend Favorite

Safety of Oseltamivir in Pregnancy: A Review of Preclinical and Clinical Data

By Donner Barbara

Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite

Preclinical Drug Safety Analysis by Chemogenomic Profiling in the Liver

By Fielden Mark R. Pearson Cecelia Brennan Richard Kolaja Kyle L.

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 161-171

Adis International

Access to resources Recommend Favorite